Date,Open,High,Low,Close,Volume,Dividends,Stock Splits,SMA_10,SMA_40,SMA_120,Close_10_%_D,10_40_%_D,40_120_%_D,RSI,earningsGrowth,revenueGrowth,profitMargins,grossMargins,returnOnEquity,debtToEquity,priceToBook,forwardPE,longName,sector,longBusinessSummary
2024-08-06,0.005900000222027302,0.25,0.005900000222027302,0.17990000545978546,755394,0.0,0.0,,,,,,,,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-07,0.20000000298023224,0.2199999988079071,0.18029999732971191,0.20000000298023224,2104578,0.0,0.0,,,,,,,100.0,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-08,0.20000000298023224,0.21199999749660492,0.19020000100135803,0.20149999856948853,739448,0.0,0.0,,,,,,,100.0,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-09,0.20999999344348907,0.2619999945163727,0.20250000059604645,0.2619999945163727,770092,0.0,0.0,,,,,,,100.0,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-12,0.28200000524520874,0.367000013589859,0.2759999930858612,0.3449999988079071,629022,0.0,0.0,,,,,,,100.0,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-13,0.3499999940395355,0.7990000247955322,0.2919999957084656,0.7260000109672546,553209,0.0,0.0,,,,,,,100.0,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-14,0.6000000238418579,0.6000000238418579,0.3504999876022339,0.4415000081062317,726912,0.0,0.0,,,,,,,63.20882159500103,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-15,0.40400001406669617,0.47749999165534973,0.36149999499320984,0.3799999952316284,588548,0.0,0.0,,,,,,,58.22216286007799,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-16,0.38999998569488525,0.44999998807907104,0.33500000834465027,0.34950000047683716,937977,0.0,0.0,,,,,,,55.86816739805086,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-19,0.34950000047683716,0.5,0.34950000047683716,0.4000000059604645,1537546,0.0,0.0,0.34854000210762026,,,14.764446990780325,,,58.835820246818784,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-20,0.41999998688697815,0.46000000834465027,0.40049999952316284,0.44999998807907104,769452,0.0,0.0,0.3755500003695488,,,19.824254463123946,,,61.58985956675238,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-21,0.44999998807907104,0.44999998807907104,0.390500009059906,0.43849998712539673,659937,0.0,0.0,0.39939999878406524,,,9.789681637548231,,,60.585857423961166,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-22,0.43849998712539673,0.46000000834465027,0.4205000102519989,0.42500001192092896,292769,0.0,0.0,0.42175000011920927,,,0.7706014939658706,,,59.36248889248225,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-23,0.44999998807907104,0.5099999904632568,0.43050000071525574,0.46000000834465027,678365,0.0,0.0,0.44155000150203705,,,4.178463770773671,,,61.531260008696094,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-26,0.48249998688697815,0.48249998688697815,0.46000000834465027,0.47999998927116394,351796,0.0,0.0,0.45505000054836275,,,5.4829114806581565,,,62.754486425212896,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-27,0.47999998927116394,0.47999998927116394,0.4300000071525574,0.4584999978542328,338160,0.0,0.0,0.4282999992370605,,,7.051132073539139,,,60.5263748174535,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-28,0.4584999978542328,0.4749999940395355,0.38999998569488525,0.4645000100135803,487248,0.0,0.0,0.4305999994277954,,,7.8727381864452095,,,60.9431367563769,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-29,0.4645000100135803,0.4645000100135803,0.4000000059604645,0.42399999499320984,319265,0.0,0.0,0.43499999940395356,,,-2.5287366496129127,,,56.59924112374876,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-08-30,0.4235000014305115,0.4235000014305115,0.31299999356269836,0.3894999921321869,1506266,0.0,0.0,0.4389999985694885,,,-11.275627926788331,,,53.12543401297629,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-02,0.35899999737739563,0.3799999952316284,0.23899999260902405,0.289000004529953,491891,0.0,0.0,0.4278999984264374,,,-32.46085403301618,,,44.548041778802556,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-03,0.289000004529953,0.3790000081062317,0.289000004529953,0.3255000114440918,341353,0.0,0.0,0.4154500007629395,,,-21.65121895623107,,,47.84176632853339,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-04,0.3255000114440918,0.3255000114440918,0.21050000190734863,0.32199999690055847,191008,0.0,0.0,0.4038000017404556,,,-20.257554355454037,,,47.55010192579267,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-05,0.32199999690055847,0.3499999940395355,0.26100000739097595,0.2980000078678131,284434,0.0,0.0,0.39110000133514405,,,-23.804651789696894,,,45.5016343434668,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-06,0.3034999966621399,0.328000009059906,0.2605000138282776,0.2784999907016754,237432,0.0,0.0,0.37294999957084657,,,-25.325113011892945,,,43.84874622762871,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-09,0.2784999907016754,0.2985000014305115,0.2535000145435333,0.2985000014305115,136428,0.0,0.0,0.3548000007867813,,,-15.868094484617428,,,46.01480892007248,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-10,0.2985000014305115,0.3199999928474426,0.23999999463558197,0.26750001311302185,1255015,0.0,0.0,0.33570000231266023,,,-20.315754760144173,,,43.23109991337016,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-11,0.26750001311302185,0.29649999737739563,0.2304999977350235,0.23800000548362732,436993,0.0,0.0,0.3130500018596649,,,-23.97380480121551,,,40.7073609033918,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-12,0.25,0.28299999237060547,0.20000000298023224,0.22699999809265137,934874,0.0,0.0,0.29335000216960905,,,-22.618034288813625,,,39.7749374416031,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-13,0.22699999809265137,0.26899999380111694,0.20499999821186066,0.23199999332427979,958712,0.0,0.0,0.27760000228881837,,,-16.426516062163355,,,40.44272201517878,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-16,0.23199999332427979,0.25600001215934753,0.2199999988079071,0.23800000548362732,142499,0.0,0.0,0.2725000023841858,,,-12.660549210534851,,,41.28408266538806,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-17,0.23800000548362732,0.23800000548362732,0.20100000500679016,0.22550000250339508,196890,0.0,0.0,0.2625000014901161,,,-14.095237629213567,,,40.01578450906339,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-18,0.22550000250339508,0.34950000047683716,0.22100000083446503,0.2770000100135803,989919,0.0,0.0,0.2580000028014183,,,7.3643438007193485,,,47.21129469007466,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-19,0.44999998807907104,0.44999998807907104,0.2840000092983246,0.3499999940395355,2843348,0.0,0.0,0.26320000141859057,,,32.97872042291487,,,55.38160750140494,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-20,0.38999998569488525,0.4000000059604645,0.30649998784065247,0.3395000100135803,1258123,0.0,0.0,0.26930000334978105,,,26.06758477185008,,,54.084951790106146,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-23,0.3395000100135803,0.3395000100135803,0.30000001192092896,0.3149999976158142,436417,0.0,0.0,0.2709500029683113,,,16.257609951993523,,,51.0797722640989,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-24,0.3149999976158142,0.32749998569488525,0.2815000116825104,0.3095000088214874,66563,0.0,0.0,0.2751500025391579,,,12.484101750077588,,,50.40271086617107,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-25,0.3095000088214874,0.3384999930858612,0.25,0.3100000023841858,452994,0.0,0.0,0.2823500022292137,,,9.792810319344584,,,50.466988683967024,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-26,0.3100000023841858,0.32600000500679016,0.28049999475479126,0.2985000014305115,555017,0.0,0.0,0.28950000256299974,,,3.1088078714449052,,,48.897325623476405,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-27,0.3199999928474426,0.34850001335144043,0.28450000286102295,0.31200000643730164,321069,0.0,0.0,0.2975000038743019,,,4.87395037787165,,,50.830690790673785,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-09-30,0.3199999928474426,0.33000001311302185,0.28600001335144043,0.32249999046325684,872734,0.0,0.0,0.3059500023722649,0.33872250132262705,,5.409376683336234,-9.67532384839912,,52.34096193782431,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-01,0.3215000033378601,0.3215000033378601,0.2904999852180481,0.3125,126725,0.0,0.0,0.31465000212192534,0.3420375011861324,,-0.683299573312009,-8.007162655916826,,50.74240718692357,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-02,0.3084999918937683,0.3084999918937683,0.2849999964237213,0.2849999964237213,79406,0.0,0.0,0.31545000076293944,0.3441625010222197,,-9.652878194824064,-8.342716064068384,,46.53349970199152,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-03,0.2849999964237213,0.32850000262260437,0.28200000524520874,0.30000001192092896,368350,0.0,0.0,0.3104500025510788,0.34662500135600566,,-3.3660784487932123,-10.43635013729805,,49.01756238678941,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-04,0.29499998688697815,0.29499998688697815,0.2720000147819519,0.289000004529953,276787,0.0,0.0,0.30540000200271605,0.34730000160634517,,-5.3700056860566745,-12.064497382617805,,47.282684653549246,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-07,0.289000004529953,0.2944999933242798,0.2745000123977661,0.28949999809265137,251990,0.0,0.0,0.3028500020503998,0.34591250158846376,,-4.408124110075703,-12.448957276859549,,47.373859450194765,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-08,0.289000004529953,0.289000004529953,0.27250000834465027,0.2800000011920929,71508,0.0,0.0,0.2999000012874603,0.33476250134408475,,-6.6355451850408125,-10.414099523288934,,45.75465914777036,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-09,0.2800000011920929,0.2849999964237213,0.25999999046325684,0.2784999907016754,406553,0.0,0.0,0.29675000011920927,0.3306875009089708,,-6.1499610480884686,-10.262710473324967,,45.490274712084016,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-10,0.2784999907016754,0.2784999907016754,0.2290000021457672,0.27250000834465027,47642,0.0,0.0,0.29415000081062315,0.3280000012367964,,-7.360187797487503,-10.320122042236084,,44.38547936808628,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-11,0.27250000834465027,0.27250000834465027,0.23999999463558197,0.2619999945163727,309092,0.0,0.0,0.2891499996185303,0.32581250108778476,,-9.389591955032351,-11.252638050059467,,42.44283953954758,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-14,0.2669999897480011,0.27000001072883606,0.2409999966621399,0.2694999873638153,86731,0.0,0.0,0.2838499993085861,0.32255000062286854,,-5.0554912734631605,-11.99814020758015,,44.31751311935364,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-15,0.2694999873638153,0.2770000100135803,0.24950000643730164,0.2770000100135803,143454,0.0,0.0,0.2803000003099442,0.31822500117123126,,-1.1773065617962395,-11.917668543233129,,46.20445708061032,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-16,0.2770000100135803,0.2770000100135803,0.23999999463558197,0.25949999690055847,819861,0.0,0.0,0.27775000035762787,0.3137500014156103,,-6.570658301915712,-11.474103871092863,,42.57874188670237,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-17,0.25949999690055847,0.27000001072883606,0.2304999977350235,0.2434999942779541,319089,0.0,0.0,0.2720999985933304,0.30921250097453595,,-10.51084324264209,-12.002264547597258,,39.52489732150409,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-18,0.24899999797344208,0.2800000011920929,0.24449999630451202,0.2644999921321869,225973,0.0,0.0,0.26964999735355377,0.30432500056922435,,-1.9098851369964642,-11.39406987622205,,45.09135265773991,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-21,0.26499998569488525,0.26499998569488525,0.20100000500679016,0.2475000023841858,264698,0.0,0.0,0.2654499977827072,0.2985125008970499,,-6.76210041380938,-11.0757516067125,,41.74179592987168,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-22,0.24650000035762787,0.26100000739097595,0.21449999511241913,0.2524999976158142,645566,0.0,0.0,0.2626999974250793,0.29336250089108945,,-3.8827559608842788,-10.452086879840703,,43.08103069650129,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-23,0.2590000033378601,0.2800000011920929,0.2524999976158142,0.27250000834465027,500035,0.0,0.0,0.2620999991893768,0.2885625008493662,,3.9679546689960357,-9.170457554983273,,48.20957830768759,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-24,0.2750000059604645,0.29899999499320984,0.22499999403953552,0.25,467200,0.0,0.0,0.2598499983549118,0.28421250097453593,,-3.7906478419362304,-8.571932105761562,,43.4648368541481,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-25,0.25,0.25600001215934753,0.22499999403953552,0.25,330975,0.0,0.0,0.25864999890327456,0.2807250011712313,,-3.344287237561263,-7.863568323396971,,43.4648368541481,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-28,0.25699999928474426,0.26600000262260437,0.23749999701976776,0.24449999630451202,221184,0.0,0.0,0.2561499997973442,0.27961250096559526,,-4.54811770527004,-8.391077325665771,,42.28501779910944,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-29,0.25600001215934753,0.27000001072883606,0.23999999463558197,0.25,532596,0.0,0.0,0.2534499987959862,0.27772500067949296,,-1.361214761244975,-8.740661382343903,,43.92423771399574,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-30,0.25,0.2524999976158142,0.23350000381469727,0.24500000476837158,195868,0.0,0.0,0.2519999995827675,0.2758000008761883,,-2.777775724597491,-8.629442065921191,,42.73591884346622,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-10-31,0.24699999392032623,0.24699999392032623,0.23250000178813934,0.24400000274181366,118448,0.0,0.0,0.25205000042915343,0.27445000074803827,,-3.1938098288567454,-8.1617781956027,,42.48833945150485,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-01,0.24449999630451202,0.2630000114440918,0.23350000381469727,0.25999999046325684,45310,0.0,0.0,0.2516000002622604,0.27398750074207784,,3.3386288522418552,-8.170993355237842,,47.708195513033296,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-04,0.25850000977516174,0.25850000977516174,0.2345000058412552,0.24449999630451202,115572,0.0,0.0,0.25129999965429306,0.27263750061392783,,-2.705930505028104,-7.826326500054752,,43.58150922951942,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-05,0.23549999296665192,0.23999999463558197,0.2134999930858612,0.2280000001192093,364685,0.0,0.0,0.24884999990463258,0.27165000028908254,,-8.378541206917294,-8.393153086761206,,39.649758276223004,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-06,0.22699999809265137,0.23899999260902405,0.20800000429153442,0.23000000417232513,155173,0.0,0.0,0.24459999948740005,0.27145000025629995,,-5.968926960618001,-9.891324643046028,,40.35219932933542,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-07,0.2199999988079071,0.23000000417232513,0.20350000262260437,0.21449999511241913,259531,0.0,0.0,0.24104999899864196,0.27113750018179417,,-11.014314041284196,-11.096768673820083,,36.779305168867786,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-08,0.21400000154972076,0.22550000250339508,0.20100000500679016,0.22550000250339508,109259,0.0,0.0,0.23859999924898148,0.27097500041127204,,-5.490359089195311,-11.94759705255224,,40.786317856186564,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-11,0.20999999344348907,0.22849999368190765,0.16519999504089355,0.19859999418258667,756772,0.0,0.0,0.23400999903678893,0.269990000128746,,-15.131834109633674,-13.326419895107172,,34.95214368018068,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-12,0.19099999964237213,0.22750000655651093,0.1736000031232834,0.19760000705718994,335519,0.0,0.0,0.22876999974250795,0.2692925002425909,,-13.625035065962052,-15.047764220532853,,34.75312883225381,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-13,0.19760000705718994,0.2199999988079071,0.18019999563694,0.1899999976158142,101932,0.0,0.0,0.2232699990272522,0.2671174999326468,,-14.901241347422173,-16.41506113094449,,33.20563863711999,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-14,0.1899999976158142,0.19200000166893005,0.18000000715255737,0.1899999976158142,190601,0.0,0.0,0.21786999851465225,0.2631175000220537,,-12.792032445423512,-17.19669026332682,,33.20563863711999,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-15,0.1899999976158142,0.19920000433921814,0.1720000058412552,0.18199999630451202,413909,0.0,0.0,0.21006999909877777,0.25917999967932703,,-13.362213983286042,-18.948221560811437,,31.493644736935224,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-18,0.1826000064611435,0.19939999282360077,0.18000000715255737,0.19200000166893005,149103,0.0,0.0,0.20481999963521957,0.25610499978065493,,-6.259153397676832,-20.024989824235835,,35.93969373356296,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-19,0.19419999420642853,0.21400000154972076,0.18000000715255737,0.21400000154972076,221303,0.0,0.0,0.20341999977827072,0.25371749959886075,,5.201062718996327,-19.824213899361588,,44.47704384051585,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-20,0.21400000154972076,0.21400000154972076,0.11999999731779099,0.11999999731779099,2123495,0.0,0.0,0.19241999909281732,0.24896749947220087,,-37.63642143044248,-22.712804080557316,,27.570167800137312,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-21,0.1436000019311905,0.1436000019311905,0.10440000146627426,0.1371999979019165,2961615,0.0,0.0,0.18468999937176706,0.244934999383986,,-25.7133584013159,-24.596321539892514,,32.61747790557608,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-22,0.14000000059604645,0.14000000059604645,0.1111999973654747,0.12880000472068787,364568,0.0,0.0,0.17501999959349632,0.24035499934107066,,-26.408407599222716,-27.18270887923662,,31.464301470166262,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-25,0.1143999993801117,0.16459999978542328,0.1143999993801117,0.149399995803833,207556,0.0,0.0,0.17009999975562096,0.23602749947458507,,-12.169314510010114,-27.932126496159842,,37.317145242784854,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-26,0.14000000059604645,0.14880000054836273,0.11999999731779099,0.14000000059604645,104165,0.0,0.0,0.1643399991095066,0.2317149994894862,,-14.810757359954351,-29.076667685915886,,35.81417519677896,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-27,0.13500000536441803,0.1436000019311905,0.12800000607967377,0.13779999315738678,170867,0.0,0.0,0.15911999866366386,0.22803499940782784,,-13.398696383439354,-30.22123837267338,,35.45426709342594,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-28,0.13779999315738678,0.1459999978542328,0.12800000607967377,0.1444000005722046,151296,0.0,0.0,0.1545599989593029,0.22414499912410973,,-6.573497965520512,-31.044636479387805,,37.48397247148925,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-11-29,0.1444000005722046,0.1444000005722046,0.11999999731779099,0.14079999923706055,473325,0.0,0.0,0.15043999925255774,0.22043999899178743,,-6.407870289412608,-31.754672500174326,,36.804135147128044,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-02,0.14079999923706055,0.14079999923706055,0.11999999731779099,0.12839999794960022,514661,0.0,0.0,0.14407999888062478,0.21641249898821116,,-10.88284359581095,-33.4234392402292,,34.48416267785613,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-03,0.12780000269412994,0.12999999523162842,0.11559999734163284,0.12720000743865967,310940,0.0,0.0,0.13539999946951867,0.21259249914437534,,-6.056124123327627,-36.31007678329887,,34.259100284629724,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-04,0.12880000472068787,0.12880000472068787,0.11699999868869781,0.1273999959230423,247941,0.0,0.0,0.13613999933004378,0.20881499927490949,,-6.419864441025243,-34.80353432331146,,34.33601728312459,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-05,0.125,0.14800000190734863,0.12099999934434891,0.1356000006198883,515386,0.0,0.0,0.13597999960184098,0.20539249908179044,,-0.2794521128587602,-33.795050836938465,,37.56176994345953,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-06,0.14480000734329224,0.15299999713897705,0.1324000060558319,0.15000000596046448,626408,0.0,0.0,0.13809999972581863,0.20259249936789275,,8.616948774997768,-31.833606793586465,,42.86945836593729,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-09,0.14980000257492065,0.14980000257492065,0.12600000202655792,0.14000000059604645,948404,0.0,0.0,0.13716000020504,0.19935499969869852,,2.0705747934973404,-31.198113710545964,,40.30699579679285,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-10,0.14959999918937683,0.14959999918937683,0.12860000133514404,0.14339999854564667,288011,0.0,0.0,0.1375,0.19601499941200018,,4.290908033197568,-29.8523070109592,,41.58547448440615,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-11,0.14339999854564667,0.14880000054836273,0.13099999725818634,0.14800000190734863,517353,0.0,0.0,0.1385200008749962,0.19322749953716994,,6.843777773945746,-28.312480776914477,,43.35317941311235,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-12,0.13500000536441803,0.14000000059604645,0.12300000339746475,0.12700000405311584,522276,0.0,0.0,0.1367800012230873,0.19031499978154898,,-7.150166020265165,-28.129679016320964,,37.73856331090575,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-13,0.1298000067472458,0.13500000536441803,0.11599999666213989,0.12759999930858612,484454,0.0,0.0,0.13546000123023988,0.18689249996095897,,-5.802452273933026,-27.51983024544223,,37.985681287840336,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-16,0.12800000607967377,0.12800000607967377,0.11500000208616257,0.121799997985363,416283,0.0,0.0,0.13480000123381614,0.1837499998509884,,-9.643919235508084,-26.63945505135681,,36.47842787802027,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-17,0.11540000140666962,0.12380000203847885,0.11259999871253967,0.12160000205039978,278191,0.0,0.0,0.13424000069499015,0.18047749996185303,,-9.415970336077399,-25.619536660600883,,36.42475674367297,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-18,0.11460000276565552,0.12359999865293503,0.11460000276565552,0.12359999865293503,161273,0.0,0.0,0.13386000096797943,0.17675499971956016,,-7.664726012887664,-24.2680539841238,,37.41640564769902,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-19,0.12359999865293503,0.14079999923706055,0.11240000277757645,0.12999999523162842,433459,0.0,0.0,0.13330000042915344,0.17375499960035085,,-2.4756227958745676,-23.282782805816726,,40.60887421910135,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-20,0.13899999856948853,0.16979999840259552,0.11959999799728394,0.15800000727176666,567953,0.0,0.0,0.13410000056028365,0.171454999782145,,17.822525437454377,-21.7870574024237,,52.11712904266412,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-23,0.1599999964237213,0.1599999964237213,0.14000000059604645,0.1573999971151352,414399,0.0,0.0,0.13584000021219253,0.1692774998024106,,15.871611358410107,-19.753067967832727,,51.88511420664009,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-27,0.1573999971151352,0.2199999988079071,0.14480000734329224,0.2199999988079071,730199,0.0,0.0,0.14350000023841858,0.16852749977260828,,53.31010344417236,-14.850691767194638,,67.92748908082723,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2024-12-30,0.2199999988079071,0.3499999940395355,0.18060000240802765,0.3499999940395355,1479946,0.0,0.0,0.16369999945163727,0.17115249950438738,,113.80573928647924,-4.354303953684925,,81.6273232497796,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-02,0.3499999940395355,0.3499999940395355,0.18039999902248383,0.2630000114440918,844880,0.0,0.0,0.17730000019073486,0.17162749972194433,,48.33615970736776,3.305123292001931,,62.41324265469807,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-03,0.2630000114440918,0.33000001311302185,0.226500004529953,0.25600001215934753,134172,0.0,0.0,0.190140001475811,0.1715275002643466,,34.63764077645441,10.851030407823863,,61.16569968209349,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-07,0.25600001215934753,0.25600001215934753,0.21400000154972076,0.21549999713897705,342283,0.0,0.0,0.19951000139117242,0.17080250028520821,,8.014633670646713,16.80742439837125,,54.39158764568332,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-08,0.2150000035762787,0.2150000035762787,0.18119999766349792,0.20999999344348907,279576,0.0,0.0,0.20835000053048133,0.1703525001183152,,0.7919332415678828,22.30522028486559,,53.5246443395907,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-09,0.20999999344348907,0.20999999344348907,0.18140000104904175,0.20550000667572021,67498,0.0,0.0,0.21654000133275986,0.1697400001809001,,-5.098362699312234,27.571580712844785,,52.78335308550129,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-10,0.20550000667572021,0.20550000667572021,0.18019999563694,0.20250000059604645,266919,0.0,0.0,0.22379000186920167,0.16944000031799078,,-9.513383571799856,32.076252035653546,,52.26367949185614,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-13,0.20100000500679016,0.2094999998807907,0.1899999976158142,0.20399999618530273,194600,0.0,0.0,0.22839000076055527,0.16890250016003847,,-10.679103504545754,35.220023708441985,,52.51541175537259,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-14,0.20000000298023224,0.20000000298023224,0.18160000443458557,0.19740000367164612,194363,0.0,0.0,0.23239000141620636,0.16887250039726495,,-15.056584849317064,37.61269648374919,,51.23515769562981,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-15,0.20000000298023224,0.2045000046491623,0.15520000457763672,0.20250000059604645,353312,0.0,0.0,0.2306400015950203,0.16899500023573638,,-12.200832814935868,36.47741132772768,,52.204785272022356,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-16,0.20250000059604645,0.20499999821186066,0.1565999984741211,0.19859999418258667,144188,0.0,0.0,0.21550000160932542,0.16921000014990567,,-7.842230765907998,27.356540049885197,,51.36371048544259,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-17,0.19740000367164612,0.19740000367164612,0.16500000655651093,0.19300000369548798,42993,0.0,0.0,0.20850000083446502,0.16928500030189753,,-7.434051355847713,23.165076919179313,,50.115176927845305,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-20,0.19480000436306,0.19480000436306,0.16500000655651093,0.17820000648498535,537009,0.0,0.0,0.2007200002670288,0.16919000055640937,,-11.219606293385745,18.635852950486314,,46.87237922550136,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-21,0.1599999964237213,0.17820000648498535,0.1599999964237213,0.16979999840259552,151436,0.0,0.0,0.19615000039339064,0.168635000474751,,-13.433597725184098,16.31630435032931,,45.089078042664646,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-22,0.16899999976158142,0.1889999955892563,0.1550000011920929,0.16979999840259552,514912,0.0,0.0,0.1921300008893013,0.16753000039607285,,-11.622340281761387,14.683937464973052,,45.089078042664646,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-23,0.17100000381469727,0.18379999697208405,0.16040000319480896,0.17499999701976776,56853,0.0,0.0,0.18907999992370605,0.16890500038862227,,-7.446584995567795,11.94458393100528,,46.549087646165376,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-24,0.18780000507831573,0.18780000507831573,0.15000000596046448,0.17440000176429749,1913141,0.0,0.0,0.18627000004053115,0.1698350004851818,,-6.372469143528658,9.677039190036284,,46.39580078784541,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-27,0.14139999449253082,0.1728000044822693,0.10999999940395355,0.131400004029274,1128513,0.0,0.0,0.1790100008249283,0.16990000046789647,,-26.596277624855645,5.3619778292780005,,36.993666894949186,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-28,0.131400004029274,0.149399995803833,0.12999999523162842,0.14000000059604645,352917,0.0,0.0,0.17327000051736832,0.1696650005877018,0.2481383337949713,-19.20124650659705,2.1247752436738243,-31.624832812857324,39.62873916710972,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-29,0.14000000059604645,0.149399995803833,0.12999999523162842,0.13500000536441803,462404,0.0,0.0,0.16652000099420547,0.16954000070691108,0.2477641671275099,-18.928654480901827,-1.7812903740199795,-31.57202565952217,38.617512264565875,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-30,0.13699999451637268,0.14800000190734863,0.13079999387264252,0.14000000059604645,274832,0.0,0.0,0.16066000163555144,0.16959500089287757,0.2472641671076417,-12.859455265269506,-5.268433155626919,-31.41141198229194,40.259212963831615,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-01-31,0.14000000059604645,0.14000000059604645,0.12099999934434891,0.13860000669956207,561743,0.0,0.0,0.15522000193595886,0.1694500010460615,0.24674000050872563,-10.707379866709394,-8.39775687356562,-31.32447082082699,39.93713012436244,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-03,0.12999999523162842,0.15880000591278076,0.12999999523162842,0.1436000019311905,541944,0.0,0.0,0.1517600014805794,0.16952000111341475,0.24575333390384912,-5.37691056258531,-10.476639639090912,-31.020263928651577,41.73010687656172,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-04,0.1436000019311905,0.1436000019311905,0.12399999797344208,0.1298000067472458,526215,0.0,0.0,0.1477600023150444,0.1695550013333559,0.24396000063667694,-12.154842505690727,-12.854235408521596,-30.498851905698427,38.32921710654622,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-05,0.12999999523162842,0.13699999451637268,0.12039999663829803,0.12600000202655792,747639,0.0,0.0,0.14338000267744064,0.16952500119805336,0.23896000056217115,-12.121635044171525,-15.422503073790242,-29.057164044512383,37.42475188262747,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-06,0.12300000339746475,0.1257999986410141,0.11339999735355377,0.12380000203847885,534457,0.0,0.0,0.13826000317931175,0.16943500135093928,0.23631250051160654,-10.458556927761299,-18.399384969494502,-28.300449200055144,36.882125270874,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-07,0.12399999797344208,0.12399999797344208,0.11540000140666962,0.1225999966263771,444546,0.0,0.0,0.13308000266551973,0.16911000125110148,0.23416750052322943,-7.874966808862208,-21.305658044483682,-27.7824630346918,36.57065250604266,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-10,0.1225999966263771,0.1225999966263771,0.11999999731779099,0.12099999934434891,201464,0.0,0.0,0.13204000219702722,0.1683850010856986,0.23226333384712536,-8.361104717496639,-21.584463375199192,-27.502547088844935,36.13250241799226,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-11,0.12160000205039978,0.13660000264644623,0.12020000070333481,0.12139999866485596,59506,0.0,0.0,0.13018000200390817,0.16792000103741883,0.22994166711966196,-6.744510065984348,-22.474987375149425,-26.97278264489879,36.33785310798278,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-12,0.12999999523162842,0.13699999451637268,0.12060000002384186,0.13699999451637268,233886,0.0,0.0,0.13038000091910362,0.167760000936687,0.2273333338399728,5.077460922382214,-22.281831073481378,-26.20527834480331,43.91203702199686,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-13,0.13600000739097595,0.13600000739097595,0.11999999731779099,0.133200004696846,117268,0.0,0.0,0.12970000132918358,0.16739000100642443,0.2247891673197349,2.6985376498025526,-22.516279019434567,-25.534667438697,42.58301075698225,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-14,0.11999999731779099,0.1599999964237213,0.11999999731779099,0.15000000596046448,258923,0.0,0.0,0.1308400012552738,0.16796500105410814,0.22249750060339768,14.643843259989556,-22.10281878120246,-24.509263879999196,49.81467545605308,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-17,0.1599999964237213,0.1599999964237213,0.12999999523162842,0.14339999854564667,189813,0.0,0.0,0.13082000091671944,0.16836000103503465,0.21985916718840598,9.616264746042697,-22.297457761658823,-23.42370655358649,47.294513668626784,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-18,0.14319999516010284,0.14800000190734863,0.1289999932050705,0.14319999516010284,74550,0.0,0.0,0.13215999975800513,0.16889500096440316,0.21705250057081382,8.35350743213739,-21.75020041838918,-22.18702824421006,47.216558833672465,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-19,0.14300000667572021,0.17900000512599945,0.12700000405311584,0.14319999516010284,108536,0.0,0.0,0.13387999907135964,0.16943500079214574,0.21442500054836272,6.961455148931944,-20.984449231008163,-20.981695064083567,47.21655883367247,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-20,0.1469999998807907,0.1469999998807907,0.125,0.14339999854564667,90297,0.0,0.0,0.13583999872207642,0.16993000078946352,0.2117491671194633,5.565370947211012,-20.061202794686768,-19.74938881644172,47.317268219098004,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-21,0.1428000032901764,0.1428000032901764,0.125,0.13699999451637268,32278,0.0,0.0,0.13727999851107597,0.17010500077158214,0.20935750044882298,-0.20396561606948277,-19.296906094244545,-18.749029575291495,44.39806788570799,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-24,0.13699999451637268,0.14980000257492065,0.12759999930858612,0.14380000531673431,162843,0.0,0.0,0.13955999910831451,0.16975000072270632,0.2073100005586942,3.038124273079903,-17.78497878401098,-18.117794479168783,48.06433396315921,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-25,0.1436000019311905,0.1679999977350235,0.13279999792575836,0.15940000116825104,631295,0.0,0.0,0.143359999358654,0.1698000008240342,0.20623000053068002,11.188617383757517,-15.571261093679434,-17.66474306012828,55.33970646475568,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-26,0.1599999964237213,0.1599999964237213,0.13860000669956207,0.15000000596046448,232493,0.0,0.0,0.1446600005030632,0.16805000100284814,0.20476750048498313,3.6914181106256723,-13.918476858199192,-17.931312046673007,50.728355811471125,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-27,0.12999999523162842,0.14980000257492065,0.12999999523162842,0.14880000054836273,1418,0.0,0.0,0.14622000008821487,0.16302000116556883,0.20332416718204815,1.7644648191706624,-10.305484576884092,-19.822614583928242,50.153795847773864,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-02-28,0.14499999582767487,0.15459999442100525,0.13040000200271606,0.14300000667572021,167661,0.0,0.0,0.14552000015974045,0.16002000104635955,0.20203250050544738,-1.7317162460513933,-9.061367823899893,-20.79492128938683,47.361635966250944,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-03,0.14300000667572021,0.2084999978542328,0.13500000536441803,0.18000000715255737,3249078,0.0,0.0,0.14918000102043152,0.15812000092118977,0.20121166730920473,20.65960981452519,-5.653933625521624,-21.416087329466535,61.92435867938975,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-04,0.18000000715255737,0.18000000715255737,0.1501999944448471,0.17299999296665192,698118,0.0,0.0,0.15216000080108644,0.15705750081688166,0.20016583390533924,13.696104137649742,-3.11828469848465,-21.536309292845655,58.62013899056368,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-05,0.17299999296665192,0.17299999296665192,0.16179999709129333,0.16179999709129333,86226,0.0,0.0,0.15402000099420549,0.15585250090807676,0.1992850004384915,5.051289473359078,-1.1757911507317402,-21.794163853199784,53.684327754178774,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-06,0.16200000047683716,0.18979999423027039,0.16200000047683716,0.18880000710487366,100176,0.0,0.0,0.15856000185012817,0.1554350009188056,0.19887500045200188,19.07164789473736,2.010487285907353,-21.84286583756938,61.99259822286584,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-07,0.18880000710487366,0.18880000710487366,0.1599999964237213,0.18400000035762787,215668,0.0,0.0,0.1632600024342537,0.15497250091284515,0.19851666713754337,12.703661407653325,5.347723933337927,-21.934765907856196,59.93424318872742,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-10,0.18479999899864197,0.18479999899864197,0.13899999856948853,0.16940000653266907,679934,0.0,0.0,0.16582000255584717,0.1541075011715293,0.1979950005809466,2.1589699201796693,7.600214976739695,-22.16596342364448,54.055117189282164,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-11,0.16940000653266907,0.1777999997138977,0.12359999865293503,0.1289999932050705,1070851,0.0,0.0,0.1627800017595291,0.1523975009098649,0.19708666714529197,-20.751940158079734,6.812776316984961,-22.674880489242984,41.82812447028692,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-12,0.1289999932050705,0.1348000019788742,0.12080000340938568,0.1316000074148178,486005,0.0,0.0,0.16094000190496444,0.1506250010803342,0.19630416718622049,-18.230392781697606,6.848133278438187,-23.269585541988803,42.72600634350859,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-13,0.1316000074148178,0.1316000074148178,0.12600000202655792,0.13099999725818634,564357,0.0,0.0,0.1591600015759468,0.1489350011572242,0.19508750041325887,-17.692890197870025,6.865411313173145,-23.657332816438085,42.56273752333722,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-14,0.13099999725818634,0.13840000331401825,0.11779999732971191,0.11999999731779099,866854,0.0,0.0,0.15686000064015387,0.14711000099778176,0.193170833773911,-23.498663248715598,6.627693274585137,-23.84461042914961,39.57686598972598,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-17,0.11999999731779099,0.13860000669956207,0.1151999980211258,0.11999999731779099,1168419,0.0,0.0,0.15085999965667723,0.14565500076860188,0.1913416670014461,-20.45605356563472,3.5735119704845504,-23.877008572575527,39.57686598972598,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-18,0.125,0.12780000269412994,0.11540000140666962,0.12120000272989273,284945,0.0,0.0,0.14568000063300132,0.14444000087678432,0.1897266670440634,-16.803952359101697,0.8584877794862302,-23.869425881371438,40.108444052525954,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-19,0.12359999865293503,0.12359999865293503,0.11559999734163284,0.12080000340938568,130106,0.0,0.0,0.14158000126481057,0.14321500100195408,0.18815416699896256,-14.677212649940637,-1.141639999793878,-23.88422574625002,39.98217673057053,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-20,0.12200000137090683,0.12200000137090683,0.12080000340938568,0.12080000340938568,29408,0.0,0.0,0.13478000089526176,0.14186000116169453,0.18657750034083923,-10.372456887531861,-4.990836182471801,-23.967251730489956,39.98217673057053,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-21,0.12080000340938568,0.1298000067472458,0.10999999940395355,0.11959999799728394,510404,0.0,0.0,0.12834000065922738,0.1404900010675192,0.18508666697889567,-6.810037881447567,-8.64830259518081,-24.095018101148028,39.54898139138283,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-24,0.1340000033378601,0.1340000033378601,0.11219999939203262,0.12359999865293503,879319,0.0,0.0,0.12375999987125397,0.1402950009331107,0.18351666691402593,-0.12928346677875446,-11.78588043186245,-23.551902237393925,41.81212131839175,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-25,0.1234000027179718,0.1234000027179718,0.11299999803304672,0.12139999866485596,281933,0.0,0.0,0.12300000041723251,0.13983000088483094,0.18184083364903927,-1.3008144284139291,-12.036044025673881,-23.103079721516824,40.90506925608629,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-26,0.12099999934434891,0.12099999934434891,0.05999999865889549,0.11999999731779099,91373,0.0,0.0,0.12183999940752983,0.1394550006836653,0.18023666696002086,-1.5101790041744982,-12.631315614197794,-22.626731266286424,40.305846200172674,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-27,0.11980000138282776,0.11999999731779099,0.11020000278949738,0.11959999799728394,22333,0.0,0.0,0.12069999948143958,0.13894500061869622,0.17885833363980055,-0.9113516892142157,-13.131095797628586,-22.315612702444746,40.12498651702494,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-28,0.11959999799728394,0.13379999995231628,0.11959999799728394,0.12020000070333481,95798,0.0,0.0,0.12071999981999397,0.13848500046879053,0.17736000021298726,-0.4307481092068706,-12.828104551871771,-21.91869626607617,40.555871467478504,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-03-31,0.13099999725818634,0.13099999725818634,0.10499999672174454,0.12139999866485596,253814,0.0,0.0,0.12085999995470047,0.13793000038713216,0.17596333349744478,0.4467968809845166,-12.375843097600828,-21.614351327837806,41.4631837334928,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-01,0.12099999934434891,0.12099999934434891,0.10999999940395355,0.11479999870061874,304582,0.0,0.0,0.12021999955177307,0.1375550001859665,0.17450750016917785,-4.508401989155044,-12.602232278548586,-21.17530762138442,38.02546413850597,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-02,0.11479999870061874,0.13459999859333038,0.10740000009536743,0.11500000208616257,1797461,0.0,0.0,0.11963999941945076,0.13728000018745662,0.17313250017662843,-3.8782993612534544,-12.849650891548903,-20.708128140352255,38.19269856423154,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-03,0.11840000003576279,0.11840000003576279,0.07999999821186066,0.11479999870061874,69972,0.0,0.0,0.11903999894857406,0.13705500010401012,0.17176833357661964,-3.5618281967450454,-13.144358937481007,-20.209390607568047,38.082031804296435,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-04,0.11500000208616257,0.11840000003576279,0.10140000283718109,0.11379999667406082,371934,0.0,0.0,0.11845999881625176,0.1368350001052022,0.1704458334793647,-3.9338191699792766,-13.428582800323946,-19.719363441190634,37.49699719809953,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-07,0.11259999871253967,0.11819999665021896,0.09080000221729279,0.10920000076293945,298482,0.0,0.0,0.1170199990272522,0.13654000014066697,0.1691725001980861,-6.682616928147117,-14.296177745206364,-19.289482640032716,34.845169653995924,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-08,0.10859999805688858,0.11680000275373459,0.09319999814033508,0.10459999740123749,428834,0.0,0.0,0.11533999890089035,0.1361200001090765,0.16779833361506463,-9.311601874456022,-15.265942691400666,-18.878812931872954,32.37913372844979,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-09,0.10459999740123749,0.11060000211000443,0.09399999678134918,0.10440000146627426,104976,0.0,0.0,0.11377999931573868,0.13530500028282405,0.16636000021050373,-8.243977769269438,-15.908503693205942,-18.667347853080198,32.272195488933846,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-10,0.10419999808073044,0.10999999940395355,0.094200000166893,0.10599999874830246,469917,0.0,0.0,0.11241999939084053,0.13462500013411044,0.16508083355923495,-5.710728231031414,-16.493965252478944,-18.449042671084058,34.14603542369329,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-11,0.10499999672174454,0.11800000071525574,0.09009999781847,0.1120000034570694,764738,0.0,0.0,0.11159999966621399,0.13367500007152558,0.16398500030239424,0.35842633696396226,-16.51393334093877,-18.483397978458964,40.764600511054375,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-14,0.1120000034570694,0.11860000342130661,0.0989999994635582,0.11500000208616257,1394252,0.0,0.0,0.11096000000834465,0.13296500016003848,0.1627391670520107,3.6409535666132795,-16.549467999254176,-18.295636773448965,43.805684749515336,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-15,0.11479999870061874,0.11860000342130661,0.10300000011920929,0.1136000007390976,1034798,0.0,0.0,0.11084000021219254,0.13222500029951334,0.16162333370496829,2.4900762555226486,-16.173189668277516,-18.18941159765921,42.70387528811399,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-16,0.1136000007390976,0.1136000007390976,0.10499999672174454,0.10980000346899033,399286,0.0,0.0,0.11032000035047532,0.13139000050723554,0.16043416708707808,-0.47135322682470465,-16.036228080842356,-18.10347951884737,39.77923809230268,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-17,0.10939999669790268,0.10939999669790268,0.10440000146627426,0.10859999805688858,179901,0.0,0.0,0.1097000002861023,0.13052000049501658,0.1590683336680134,-1.0027367605696147,-15.95157840174021,-17.94721332316158,38.87382536756487,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-22,0.10840000212192535,0.11840000003576279,0.09200000017881393,0.10740000009536743,816272,0.0,0.0,0.10906000062823296,0.12978000063449144,0.1578800003354748,-1.5220984075767472,-15.965479969917459,-17.798327616718055,37.94376206584028,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-23,0.10700000077486038,0.10779999941587448,0.09799999743700027,0.10580000281333923,363632,0.0,0.0,0.10872000083327293,0.12883000057190658,0.15667833369225265,-2.6857965393245817,-15.609717961158612,-17.774208126980547,36.68353212161222,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-24,0.11840000003576279,0.11840000003576279,0.09939999878406525,0.10700000077486038,673004,0.0,0.0,0.10896000117063523,0.1275200005620718,0.1555325003961722,-1.7988256008784516,-14.554579132394437,-18.010705005543528,38.33768326996704,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-25,0.10740000009536743,0.11599999666213989,0.10400000214576721,0.11479999870061874,593669,0.0,0.0,0.11000000089406967,0.12664000038057566,0.15440583371867736,4.363634334122861,-13.139607893635377,-17.982373249374884,47.87086165832487,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-28,0.12720000743865967,0.12720000743865967,0.1080000028014183,0.125,752257,0.0,0.0,0.11190000101923943,0.12604500036686658,0.15340583367894092,11.706880126398064,-11.222182003615153,-17.835588553520797,57.19137062136906,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-29,0.11559999734163284,0.12399999797344208,0.09399999678134918,0.10700000077486038,2113905,0.0,0.0,0.11140000075101852,0.1251450002193451,0.152264166995883,-3.94973065214985,-10.983258974977298,-17.810603316321398,42.68668166487738,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-04-30,0.10660000145435333,0.10660000145435333,0.09520000219345093,0.10660000145435333,176541,0.0,0.0,0.1105600006878376,0.12331000007689,0.15098583375414212,-3.581764841577008,-10.339793513179899,-18.33008633268078,42.429159983338195,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-02,0.10400000214576721,0.11800000071525574,0.10279999673366547,0.10920000076293945,765536,0.0,0.0,0.11012000069022179,0.12171500027179719,0.14985833379129568,-0.8354521626551635,-9.526352179832426,-18.779958916861492,44.7618611356939,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-05,0.10920000076293945,0.10920000076293945,0.09449999779462814,0.09529999643564224,664727,0.0,0.0,0.10866999998688698,0.1200525002554059,0.14875250042726595,-12.3033068490458,-9.48126881514604,-19.293793441739968,36.29488479554669,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-06,0.10520000010728836,0.1120000034570694,0.0949999988079071,0.10140000283718109,647542,0.0,0.0,0.10795000046491623,0.11786750014871358,0.1476808337494731,-6.0676216762628865,-8.41410878425726,-20.18767963575767,41.52256004728428,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-07,0.10000000149011612,0.1080000028014183,0.09369999915361404,0.10660000145435333,597796,0.0,0.0,0.10787000060081482,0.11593250017613173,0.14678166713565588,-1.1773423003502759,-6.954477444260984,-21.01704358693058,45.61928519785288,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-08,0.10899999737739563,0.1265999972820282,0.09799999743700027,0.1080000028014183,1187838,0.0,0.0,0.10809000059962273,0.11439750008285046,0.14580250047147275,-0.08326190924708134,-5.513668986349902,-21.53941138668393,46.70189059823919,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-09,0.12600000202655792,0.12600000202655792,0.10779999941587448,0.11580000072717667,339898,0.0,0.0,0.10897000059485436,0.11406750027090311,0.145112500526011,6.267780210184587,-4.468844906693414,-21.393746329623173,52.3889030833529,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-12,0.11580000072717667,0.11940000206232071,0.10520000010728836,0.10639999806880951,966767,0.0,0.0,0.10813000053167343,0.1134375000372529,0.1443525004511078,-1.5999282848030414,-4.678787441398559,-21.416324841789503,46.01648847092707,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-13,0.10999999940395355,0.11259999871253967,0.10639999806880951,0.11079999804496765,292192,0.0,0.0,0.1067100003361702,0.11293250005692243,0.1436925004546841,3.832815758516226,-5.509928247064258,-21.40682380808201,49.13530985872837,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-14,0.11079999804496765,0.11500000208616257,0.10639999806880951,0.1120000034570694,904956,0.0,0.0,0.10721000060439109,0.1127325002104044,0.14304250050336123,4.467869439114728,-4.898764416389323,-21.189506745405783,49.98400842741073,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-15,0.10760000348091125,0.11180000007152557,0.10740000009536743,0.11180000007152557,41051,0.0,0.0,0.10773000046610832,0.11252750027924777,0.142457500534753,3.7779630444702947,-4.26340210280508,-21.00977494561875,49.83476051405501,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-16,0.1088000014424324,0.11140000075101852,0.07999999821186066,0.11140000075101852,302501,0.0,0.0,0.10795000046491623,0.1122825002297759,0.14178583386043708,3.1959242901750056,-3.858570797758867,-20.808378966619443,49.5163172160642,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-19,0.10019999742507935,0.10019999742507935,0.06469999998807907,0.09849999845027924,1468766,0.0,0.0,0.10827000066637993,0.11172500010579825,0.1408233338346084,-9.023738945200249,-3.0924139057029327,-20.663005864486227,40.52305707072712,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-20,0.09839999675750732,0.10999999940395355,0.08950000256299973,0.10999999940395355,268877,0.0,0.0,0.10913000032305717,0.11145500000566244,0.14074000051865976,0.7972134869613561,-2.086043409884842,-20.80787296083221,49.353994188033866,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-21,0.10100000351667404,0.10980000346899033,0.10100000351667404,0.1088000014424324,203135,0.0,0.0,0.10935000032186508,0.11118500009179115,0.14050333388149738,-0.5029710816769888,-1.6504022740577846,-20.866646349070802,48.54403829187147,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-22,0.1088000014424324,0.10999999940395355,0.09139999747276306,0.10300000011920929,980557,0.0,0.0,0.10885000005364417,0.110670000128448,0.14028833384315173,-5.374368333993431,-1.6445288449367195,-21.112470939898873,44.723641344229875,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-23,0.10980000346899033,0.10980000346899033,0.09610000252723694,0.10339999943971634,117883,0.0,0.0,0.10760999992489814,0.11022000014781952,0.13990500054011742,-3.912276264399215,-2.367991489222485,-21.217969534824313,45.04485705152253,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-26,0.09719999879598618,0.1080000028014183,0.09470000118017197,0.10140000283718109,463436,0.0,0.0,0.10711000040173531,0.10975500028580427,0.13958333389212688,-5.330965869795393,-2.4099128761161968,-21.369552348831704,43.67814744947326,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-27,0.10140000283718109,0.10279999673366547,0.09200000017881393,0.10180000215768814,192246,0.0,0.0,0.10621000081300735,0.10931000038981438,0.13928333396712939,-4.152150100331351,-2.835970694128628,-21.519684174410024,44.04382117887417,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-28,0.10199999809265137,0.10239999741315842,0.09489999711513519,0.10239999741315842,27531,0.0,0.0,0.10525000020861626,0.10886500030755997,0.138933333940804,-2.707841130459711,-3.3206265454744774,-21.64227459340708,44.62459494616963,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-05-30,0.10199999809265137,0.10199999809265137,0.07999999821186066,0.09290000051259995,1006632,0.0,0.0,0.1033600002527237,0.10815250035375357,0.13853416728476683,-10.119968764075264,-4.431242999795835,-21.930811385007708,37.914553286195456,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-02,0.09629999846220016,0.0966000035405159,0.07999999821186066,0.09130000323057175,475653,0.0,0.0,0.10135000050067902,0.10756500046700239,0.13822500066210827,-9.91612947257947,-5.777901677441945,-22.18122629643129,36.9079658526598,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-03,0.09120000153779984,0.09459999948740005,0.08100000023841858,0.09390000253915787,80766,0.0,0.0,0.10089000090956687,0.10703750047832727,0.13794750062127908,-6.92833611595912,-5.743313830469288,-22.407075158115468,39.70911288680072,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-04,0.08950000256299973,0.09430000185966492,0.0803999975323677,0.08560000360012054,504351,0.0,0.0,0.09845000132918358,0.10630750060081481,0.1375991673519214,-13.052308334762715,-7.391293396254498,-22.74117449495572,34.45076060047873,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-05,0.09399999678134918,0.09399999678134918,0.0820000022649765,0.08669999986886978,347646,0.0,0.0,0.09624000117182732,0.10563000068068504,0.1371916673456629,-9.912719437653351,-8.88951950047154,-23.005527431528545,35.666648479921264,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-09,0.08780000358819962,0.11779999732971191,0.08780000358819962,0.10119999945163727,1318554,0.0,0.0,0.09606000110507011,0.10543000064790249,0.13678500062475601,5.350820619859293,-8.887412961444191,-22.92283498456829,49.07605052628831,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-10,0.10100000351667404,0.10119999945163727,0.08150000125169754,0.08980000019073486,1367209,0.0,0.0,0.09470000118017197,0.10506000071763992,0.13636666728804508,-5.174235404828117,-9.86103128374382,-22.95771187564231,41.714319940678884,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-11,0.08940000087022781,0.0957999974489212,0.0851999968290329,0.09510000050067902,78258,0.0,0.0,0.09407000094652176,0.10482750069350004,0.13596416730433702,1.0949288229972487,-10.262096945754337,-22.900641564730694,45.786033803422306,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-12,0.09380000084638596,0.09380000084638596,0.07900000363588333,0.08489999920129776,2117951,0.0,0.0,0.09238000065088273,0.10430000070482492,0.13543833394845325,-8.096992202731156,-11.428571403059232,-22.990782842529153,39.995302846368666,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-13,0.08340000361204147,0.08789999783039093,0.07900000363588333,0.08190000057220459,777179,0.0,0.0,0.09033000096678734,0.10354750063270331,0.13506250058611233,-9.332448028736657,-12.764672816971402,-23.33364169673127,38.45482071018153,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-16,0.08129999786615372,0.08129999786615372,0.07649999856948853,0.07980000227689743,406976,0.0,0.0,0.08902000114321709,0.10266750063747168,0.13466416727751493,-10.357221689411517,-13.292911008367833,-23.760341958009327,37.3697684570074,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-17,0.0812000036239624,0.10019999742507935,0.07410000264644623,0.07959999889135361,925997,0.0,0.0,0.08785000070929527,0.10181750059127807,0.1343125006183982,-9.391009392523255,-13.718172024328092,-24.193578317362473,37.261931329277424,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-18,0.07989999651908875,0.10000000149011612,0.06019999831914902,0.07880000025033951,510982,0.0,0.0,0.08634000048041343,0.1010425005108118,0.13395583393673102,-8.732916594996317,-14.550807784913406,-24.57028742881373,36.804438088731565,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-19,0.0786999985575676,0.0786999985575676,0.06400000303983688,0.07400000095367432,331161,0.0,0.0,0.08518000021576881,0.10017750058323145,0.1335425006225705,-13.12514584852609,-14.970926884926742,-24.984555391573902,34.09923101915183,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-23,0.07400000095367432,0.0860000029206276,0.053599998354911804,0.06599999964237213,1742542,0.0,0.0,0.08311000019311905,0.09914250057190657,0.13300916732599338,-20.587174240150603,-16.17116805235247,-25.461904194229472,30.124936642923913,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-24,0.06480000168085098,0.0697999969124794,0.06019999831914902,0.06480000168085098,306981,0.0,0.0,0.07947000041604042,0.09811750054359436,0.13223250061273575,-18.459794461292606,-19.005274313188103,-25.799255032658486,29.568243204837174,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-25,0.06499999761581421,0.07940000295639038,0.06499999761581421,0.07559999823570251,1653589,0.0,0.0,0.07805000022053718,0.09733250048011541,0.13155083395540715,-3.1390159870749113,-19.810957454563244,-26.01149110684544,40.2669741737344,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-26,0.07880000025033951,0.07890000194311142,0.07020000368356705,0.07769999653100967,496835,0.0,0.0,0.07630999982357026,0.09640500042587519,0.13036500060309966,1.8215131839249221,-20.844355078610025,-26.04993673157473,42.10842086333363,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
2025-06-27,0.07779999822378159,0.09939999878406525,0.06679999828338623,0.09700000286102295,2264770,0.0,0.0,0.07752000018954278,0.09570500049740076,0.12825666734327873,25.12900235274763,-19.001097344283348,-25.380097206762358,55.6426475146301,,,-2.7468302,0.76835,,,1.1411765,,,Healthcare,"NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden."
